Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- The team shrank two years in a row.
- Little cash and receivables against the short-term debts.
Revenue
€ 644
▼ 78% vs 2024
Profit
Caution€ -3.2 million
▼ 1525% vs 2024
Debts
High€ 15 million
▲ 7% vs 2024
Oxurion from Leuven, company number BE0881620924, closed financial year 2025 with a result of € -3.2 million after tax. For that financial year Oxurion recorded revenue of € 644 and equity of € -12.2 million. Compared with financial year 2024, the result moved from € -199,230 to € -3.2 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
What happened at Oxurion?
What happened at Oxurion in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- James Hartmann stepped down as director. NBB
- MARS SARL stepped down as director. NBB
- Nelly Souleymane stepped down as director. NBB
- Charles Paris de Bollardière stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 3.2 million. Source: NBB ↗
- Nelly Souleymane became a director. NBB
- Nathalie Laarakker stepped down as director. NBB
- Anat Loewenstein stepped down as director. NBB
In short
From € 36.7 million loss in 2021 to € 3.2 million loss in 2025.
Paid € 3,002 in corporate taxes since 2021.
A new publication or filing at Oxurion? We notify you, reason included.
Follow OxurionNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of Oxurion France, 100% of Oncurious and 100% of ThromboGenics Inc. itself.
Directors
According to the 2025 annual accounts
Nathalie Laarakker
Director
since 2023 · until 2025
James Hartmann
Director
since 2023 · until 2027
since 2023 · until 2027
Nelly Souleymane
Director
since 2025 · until 2027
Anat Loewenstein
Director
since 2023 · until 2025
Charles Paris de Bollardière
Director
since 2023 · until 2027
Establishments
Establishment units
Physical locations of this company
Gaston Geenslaan 1
3001 Leuven
Werkhuizenkaai 160
1000 Brussel
Active since 30 May 2006
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
reMYND
€ -217,249 gross margin · 2025
DName-iT
€ -71,430 gross margin · 2025
miDiagnostics
€ 24,934 revenue · 2025
ALIGOS BELGIUM
€ 3.2 million gross margin · 2025
Pledge Therapeutics
€ -97,474 gross margin · 2024
+15 more
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
A2HOSTING - A2 Hosting, Inc., US
Domain
Domain
oxurion.com
Registered
2017-12-08
Registrar
Network Solutions, LLC
Expires
2026-12-08
Website info
Features
Security
Details
- Company number
- 0881.620.924
- VAT number
- BE 0881.620.924
- Registered office
- Gaston Geenslaan 1, 3001 Leuven
- Names & denominations
- Oxurion
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 May 2006
- Peppol
- Active · Active since 17 Dec 2025
- Contact
- oxurion.com info@oxurion.com +3216751310
- Activities · NACE
Activiteiten van hoofdkantoren
Activiteiten van holdings